Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance, New England Journal of Medicine, vol.378, issue.3, pp.241-249, 2018. ,
MGUS to myeloma: a mysterious gammopathy of underexplored significance, Blood, vol.128, issue.23, pp.2599-2606, 2016. ,
From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells, Cancer Research, vol.78, issue.10, pp.2449-2456, 2018. ,
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma, Frontiers in Immunology, vol.10, 2019. ,
Pellat-Deceunynck, C. The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy, Haematologica, vol.91, pp.1234-1240, 2006. ,
Why do myeloma patients have bone disease? A historical perspective, Blood Reviews, vol.41, p.100646, 2020. ,
V. Molecular classification and risk stratification of myeloma, Hematological Oncology, vol.31, issue.S1, pp.38-41, 2013. ,
Genetics of multiple myeloma: another heterogeneity level?, Blood, vol.125, issue.12, pp.1870-1876, 2015. ,
Pathogenesis beyond the cancer clone(s) in multiple myeloma, Blood, vol.125, issue.20, pp.3049-3058, 2015. ,
Multiple Myeloma Bone Marrow Niche, Current Pharmaceutical Biotechnology, vol.10, issue.3, pp.335-346, 2009. ,
The Hemopoietic Stem Cell Niche Versus the Microenvironment of the Multiple Myeloma-Tumor Initiating Cell, Cancer Microenvironment, vol.3, issue.1, pp.15-28, 2010. ,
Under one roof, OncoImmunology, vol.1, issue.3, pp.388-389, 2012. ,
Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?, Blood Cancer Journal, vol.2, issue.9, pp.e91-e91, 2012. ,
The osteoblastic niche in the context of multiple myeloma, Annals of the New York Academy of Sciences, vol.1335, issue.1, pp.45-62, 2014. ,
Osteoblastic niche supports the growth of quiescent multiple myeloma cells, Blood, vol.123, issue.14, pp.2204-2208, 2014. ,
Bone marrow niches in haematological malignancies, Nature Reviews Cancer, vol.20, issue.5, pp.285-298, 2020. ,
Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?, Journal of Bone and Mineral Research, vol.29, issue.12, pp.2529-2533, 2014. ,
Osteoblast suppression in multiple myeloma bone disease, Journal of Bone Oncology, vol.13, pp.62-70, 2018. ,
Cancer as an evolutionary and ecological process, Nature Reviews Cancer, vol.6, issue.12, pp.924-935, 2006. ,
Contributions of the Host Microenvironment to Cancer-Induced Bone Disease, Cancer Research, vol.74, issue.6, pp.1625-1631, 2014. ,
The role of host environment in cancer evolution, Evolutionary Applications, vol.13, issue.7, pp.1756-1770, 2020. ,
Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies, Blood, vol.87, issue.11, pp.4762-4769, 1996. ,
Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells, British Journal of Haematology, vol.148, issue.4, pp.551-561, 2010. ,
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche, Nature Communications, vol.6, issue.1, 2015. ,
Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice, Nature Medicine, vol.22, issue.11, pp.1351-1357, 2016. ,
Multiple Myeloma Genomics-A Concise Review, Acta Med. Acad, vol.48, pp.57-67, 2019. ,
THE BONE MARROW IN MULTIPLE MYELOMA: CORRELATION OF PLASMA CELL ULTRASTRUCTURE AND CLINICAL STATE, Medicine, vol.54, issue.3, pp.225-243, 1975. ,
Tumour Progression: Random Mutations or an Integrated Survival Response to Cellular Stress Conserved from Unicellular Organisms?, Journal of Theoretical Biology, vol.178, issue.4, pp.375-380, 1996. ,
A high bone marrow plasma cell labeling index in stable plateau?phase multiple myeloma is a marker for early disease progression and death, Blood, vol.97, issue.8, pp.2522-2523, 2001. ,
Biologic and Therapeutic Determinants of Bone Mineral Density in Multiple Myeloma, Leukemia & Lymphoma, vol.32, issue.1-2, pp.121-127, 1998. ,
Assessment of Bone Fragility in Patients With Multiple Myeloma Using QCT-Based Finite Element Modeling, Journal of Bone and Mineral Research, vol.32, issue.1, pp.151-156, 2016. ,
Molecular pathogenesis of multiple myeloma and its premalignant precursor, Journal of Clinical Investigation, vol.122, issue.10, pp.3456-3463, 2012. ,
Evolutionary biology of high-risk multiple myeloma, Nature Reviews Cancer, vol.17, issue.9, pp.543-556, 2017. ,
SnapShot: Multiple Myeloma, Cancer Cell, vol.28, issue.5, pp.678-678.e1, 2015. ,
Genomics of Multiple Myeloma, Journal of Clinical Oncology, vol.35, issue.9, pp.963-967, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01813387
Genomic landscape and chronological reconstruction of driver events in multiple myeloma, Nature Communications, vol.10, issue.1, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02290176
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing, Nature Communications, vol.8, issue.1, p.268, 2017. ,
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma, Blood Reviews, vol.41, p.100643, 2020. ,
Many Multiple Myelomas: Making More of the Molecular Mayhem, Hematology, vol.2011, issue.1, pp.344-353, 2011. ,
Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome, Journal of Clinical Oncology, vol.26, issue.29, pp.4798-4805, 2008. ,
Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS, European Journal of Clinical Investigation, vol.38, issue.1, pp.53-60, 2007. ,
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma, Leukemia, vol.17, issue.10, pp.2032-2035, 2003. ,
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma, Current Opinion in Hematology, vol.23, issue.4, pp.426-433, 2016. ,
The microenvironment in myeloma, Current Opinion in Oncology, vol.32, issue.2, pp.170-175, 2020. ,
Bone Marrow Stromal Cells Create a Permissive Microenvironment for Myeloma Development: A New Stromal Role for Wnt Inhibitor Dkk1, Cancer Research, vol.72, issue.9, pp.2183-2189, 2012. ,
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma, Cancer Research, vol.76, issue.5, pp.1089-1100, 2016. ,
Management of Myeloma with Bisphosphonates, New England Journal of Medicine, vol.334, issue.8, pp.529-530, 1996. ,
Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease., Journal of Clinical Oncology, vol.7, issue.12, pp.1909-1914, 1989. ,
Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications, Cancer, vol.66, pp.167-172, 1990. ,
PATHOGENESIS AND MANAGEMENT OF BONE LESIONS IN MULTIPLE MYELOMA, Hematology/Oncology Clinics of North America, vol.11, issue.2, pp.349-361, 1997. ,
Osteoblast stimulation in multiple myeloma lacking lytic bone lesions, British Journal of Haematology, vol.76, issue.4, pp.484-487, 1990. ,
Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma., Journal of Clinical Investigation, vol.88, issue.1, pp.62-66, 1991. ,
A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone, The American Journal of Pathology, vol.174, issue.1, pp.239-247, 2009. ,
Role of osteocytes in multiple myeloma bone disease, Current Opinion in Supportive and Palliative Care, vol.8, issue.4, pp.407-413, 2014. ,
Osteoblast and osteocyte: Games without frontiers, Archives of Biochemistry and Biophysics, vol.561, pp.3-12, 2014. ,
Pseudomyeloma, Archives of Internal Medicine, vol.135, issue.2, p.267, 1975. ,
Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development, Cell Reports, vol.14, issue.1, pp.82-92, 2016. ,
Role of the Hypoxic Bone Marrow Microenvironment in Multiple Myeloma Tumor Progression., Blood, vol.104, issue.11, pp.2348-2348, 2004. ,
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1, Frontiers in Immunology, vol.9, p.1822, 2018. ,
Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event, Frontiers in Oncology, vol.8, p.355, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01886496
The Origin of the Plasma-Cell Heterogeneity, Frontiers in Immunology, vol.6, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01820475
Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma, Blood, vol.101, issue.10, pp.4137-4139, 2003. ,
Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development, BioEssays, vol.27, issue.12, pp.1277-1285, 2005. ,
Nouveau Regard sur le Cancer. Pour une Révolution des Traitements; Belin-Pour la science, 2012. ,
Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation, International Journal of Cancer, vol.140, issue.11, pp.2408-2413, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01600555
The Maintenance of Memory Plasma Cells, Frontiers in Immunology, vol.10, 2019. ,
A Darwinian and Physical Look at Stem Cell Biology Helps Understanding the Role of Stochasticity in Development, Frontiers in Cell and Developmental Biology, vol.8, p.659, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02930016
Global Transcription in Pluripotent Embryonic Stem Cells, Cell Stem Cell, vol.2, issue.5, pp.437-447, 2008. ,
Single-Cell-Based Analysis Highlights a Surge in Cell-to-Cell Molecular Variability Preceding Irreversible Commitment in a Differentiation Process, PLOS Biology, vol.14, issue.12, p.e1002585, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01934489
Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment, PLOS Biology, vol.15, issue.7, p.e2001867, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01934491
Phenotypic instability induced by tissue disruption at the origin of cancer, Phenotypic Switching, pp.677-690, 2020. ,
, , 2020.
Spatially coordinated dynamic gene transcription in living pituitary tissue, eLife, vol.5, 2016. ,
Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors, The Hematology Journal, vol.1, issue.6, pp.362-366, 2000. ,
Stochastic gene expression stabilization as a new therapeutic strategy for cancer, BioEssays, vol.34, issue.3, pp.170-173, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01268404
Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities, Journal of Molecular Medicine, vol.94, issue.1, pp.21-35, 2015. ,
Multiple Myeloma, New England Journal of Medicine, vol.336, issue.23, pp.1657-1664, 1997. ,
URL : https://hal.archives-ouvertes.fr/hal-02192667
Bone building with bortezomib, Journal of Clinical Investigation, vol.118, pp.462-464, 2008. ,
The effects of proteasome inhibitors on bone remodeling in multiple myeloma, Bone, vol.86, pp.131-138, 2016. ,
Role of Decorin in Multiple Myeloma (MM) Bone Marrow Microenvironment, Journal of Bone and Mineral Research, vol.30, issue.3, pp.465-470, 2015. ,
Bone Anabolic Agents for the Treatment of Multiple Myeloma, Cancer Microenvironment, vol.4, issue.3, pp.339-349, 2011. ,
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma, Blood, vol.129, issue.26, pp.3452-3464, 2017. ,
Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche, Leukemia, vol.32, issue.8, pp.1739-1750, 2018. ,
Bone Disease in Multiple Myeloma: Pathophysiology and Management, Cancer Growth and Metastasis, vol.7, p.CGM.S16817, 2014. ,
, Figure 2?figure supplement 1. Representative images used in the experiment, sampled from http://commons.wikimedia.org/wiki/Main_Page under the Creative Commons Attribution 4.0 International Public License https://creativecommons.org/licenses/by/4.0/., © 2020 by the authors. Licensee MDPI